SCHEMBL14724809

SCHEMBL14724809

Cc1cccc(CNC(=O)c2cccnc2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.72
LMNA P02545 2/20 0.63
TSHR P16473 3/20 0.61
HPGD P15428 1/20 0.59
MMP13 P45452 2/20 0.58
NAMPT P43490 2/20 0.57
HTT P42858 2/20 0.56
ROCK2 O75116 1/20 0.56
THRB P10828 1/20 0.56
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13947589 0.89 LMNA (0.78) NPC1LMNATSHRHPGDMMP13
SCHEMBL8376717 0.86 NPC1 (0.72) NPC1LMNATSHRHPGDHTT
SCHEMBL30780038 0.85 GAA (0.62) HPGDMMP13NAMPTHTTROCK2
SCHEMBL14724810 0.85 GAA (0.62) HPGDMMP13NAMPTHTTROCK2
SCHEMBL6167737 0.85 TSHR (0.74) NPC1LMNATSHRHPGDMMP13
SCHEMBL7082686 0.84 TSHR (0.73) NPC1LMNATSHRMMP13NAMPT
SCHEMBL29936927 0.84 CA1 (0.66) NPC1LMNAHPGDMMP13THRB
SCHEMBL27846421 0.84 NPC1 (0.72) NPC1LMNATSHRHPGDHTT
SCHEMBL7846695 0.83 LMNA (0.69) NPC1LMNATSHRHPGDNAMPT
SCHEMBL4977146 0.83 ALDH1A1 (0.65) NPC1LMNAHPGDMMP13HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443123-B1 SMALL MOLECULE INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) RIGEL PHARMACEUTICALS INC (US) 2017-04-05 EP disclosed
EP-1523473-B1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2013-02-27 EP disclosed